🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot study evaluates the feasibility and outcomes of two treatment ap...
Status
Not Yet Recruiting
Location
Ivey Eye Institute, St. Joseph's Health Care London
Start Date
2025-08-01
Trial ID
NCT07073729
Treatments Being Tested
A prospective, longitudinal, cross-sectional, observational Study with a 8-...
Status
Completed
Location
Ophtalmology Clinic, G.d'Annunzio University
Start Date
2018-03-01
Trial ID
NCT04293549
Treatments Being Tested
To determine the efficacy and safety of nerve growth factor in the treatmen...
Status
Completed
Location
Stanford University
Start Date
2020-10-14
Trial ID
NCT04552730
Treatments Being Tested
Primary Objective To evaluate the long-term safety and efficacy (healing) ...
Status
Completed
Location
New Vision Institute
Start Date
2023-02-01
Trial ID
NCT05552261
Treatments Being Tested
Primary objectives * To compare the efficacy of cenegermin vs vehicle in S...
Status
Completed
Location
Lugene Eye Institute - Glendale Office
Start Date
2022-01-19
Trial ID
NCT05133180
Primary Objective: To assess the efficacy of cenegermin-bkbj (20 mcg/mL) o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-26
Trial ID
NCT06411145
Treatments Being Tested
TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatmen...
Status
Active Not Recruiting
Location
Toyos Clinic
Start Date
2023-01-21
Trial ID
NCT06947850
Treatments Being Tested
Neurotrophic keratopathy (NK) is a condition in which patients have fewer o...
Status
Completed
Location
University of California, Los Angeles
Start Date
2022-05-23
Trial ID
NCT04627571
Treatments Being Tested
Primary Objectives: * To compare the efficacy of cenegermin vs vehicle in ...
Status
Completed
Location
Lugene Eye Institute - Glendale Office
Start Date
2022-01-27
Trial ID
NCT05136170
Treatments Being Tested
This study is to evaluate the safety and efficacy of OXERVATE® 0.002% (20 m...
Status
Completed
Location
San Diego
Start Date
2020-09-09
Trial ID
NCT04485546
Treatments Being Tested